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The emotional distress associated with adjusting to and living with diabetes has been 
termed diabetes distress. This construct is distinct from depression and has been 
associated with glycemic control in longitudinal analyses. However, interventions to 
reduce diabetes distress have failed to consistently improve glycemic control. 
Various illness perceptions have previously been linked with both diabetes distress 
and glycemic control but interrelationships between these features have not been 
previously investigated. We hypothesized that illness perceptions mediate the 
relationship between diabetes distress and glycemic control. Participants with Type 2 
diabetes mellitus (DM) attending diabetes outpatient clinics (n = 84) completed the 
Diabetes Distress Scale 17, Brief Illness Perceptions Questionnaire and the Patient 
Health Questionnaire 9 as well as providing demographic and clinical information on 
diabetes type, duration, use of insulin, frequency of blood glucose monitoring, 
smoking status and number of complications. Most recent HbA1c and BMI were 
collected from medical records. Using regression analysis we demonstrated that the 
illness perception of personal control, regimen-related distress, socioeconomic status 
and insulin use were significant contributors in the final model predicting HbA1c. 
Higher levels of personal control were associated with improved glycemic control. 
Conversely, regimen related distress was associated with poorer glycemic control. 
Importantly, mediation analyses showed that relationship between regimen-related 
distress and HbA1c was mediated by personal control. Therefore our work suggests 
that psychological interventions designed to reduce diabetes distress may be more 
efficacious in improving glycemic control if they address an individual’s perception 
of personal control. Future work that attempts to delineate the relationship between 
3 
regimen-related distress and personal control will help to increase our understanding 




It is well established that there is an association between diabetes and depression, with 2 
estimates suggesting that up to three times as many patients with diabetes meet clinical 3 
criteria for diagnosis of depression compared to the non-diabetic population (Egede & 4 
Dismuke, 2012). However, it has recently been suggested that the understandable emotional 5 
distress specifically related to living with the demands of diabetes may account for the 6 
majority of these depressive symptoms. This has been termed diabetes distress (DD), which 7 
is defined by Fisher and colleagues (2012) as ”the unique, often hidden emotional burdens 8 
and worries that are part of the spectrum of patient experience when managing a severe, 9 
demanding chronic disease like diabetes” (p. 259). DD has been conceptualised to include 10 
four domains encompassing distress related to diabetic regimen, interpersonal issues, 11 
relationships with physicians and emotional burden. Importantly, higher levels of diabetes 12 
distress have been shown to be associated with metabolic biomarkers in prospective, 13 
longitudinal analyses (Fisher et al., 2007; Fisher et al., 2010). Specifically, high scores on a 14 
validated measure of diabetes distress have been linked to high non-HDL cholesterol (Fisher 15 
et al., 2007) and poor glycemic control (Fisher et al., 2008; Fisher et al., 2010). To date, 16 
reported interventions for DD have not translated into reductions in HbA1c – a biomarker 17 
commonly used as an index of glycemic control where higher levels of HbA1c reflect poorer 18 
glycemic control (Fisher et al., 2013; Jones, Vallis, & Pouwer, 2015). This suggests that there 19 
may be other important psychological variables that might impact upon HbA1c which have 20 
not been addressed in reported interventions.  21 
Illness perceptions, part of Leventhal’s Common Sense Model, form an important 22 
basis for understanding how individuals make sense of a chronic illness.  The common sense 23 
model (CSM) suggests that when an individual is confronted with an illness or condition, 24 
they will attempt to assign meaning to this illness by accessing their perceptions about the 25 
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illness. Furthermore, the model describes a bidirectional interaction between illness 26 
perceptions and the emotional state of an individual. In an effort to restore normal 27 
functioning, individuals will develop coping strategies (based on their illness perceptions and 28 
emotional state), which will then be evaluated in terms of their success in restoring the 29 
previous state of wellbeing. The result of this evaluation may be a change in coping strategy 30 
and/or a change in perceptions about the illness.  Key beliefs have been labelled as 31 
consequences (how much the illness is affecting their life); timeline (how long it will last); 32 
personal control (the degree of control they feel they have over their illness); treatment 33 
control (how helpful they think their treatment can be); identity (the degree to which they 34 
experience symptoms from their illness); coherence (how well they understand their illness); 35 
emotional representation (how affected they are emotionally); and concern (their degree of 36 
concern about their illness) (Broadbent, Petrie, Main, & Weinman, 2006). 37 
Illness perceptions explain a significant proportion of the variance in physical and 38 
psychological outcomes in a range of illnesses including diabetes (Dempster et al., 2011; 39 
Dorrian, Dempster, & Adair, 2009; Skinner et al., 2011). A systematic review of the literature 40 
has shown that identity; consequences; timeline/cyclical; emotional representation; concern 41 
and personal control are all significantly correlated with glycaemic control. Higher levels of 42 
positive beliefs were linked to lower HbA1c and higher levels of negative beliefs were linked 43 
to higher HbA1c (McSharry, Moss-Morris, & Kendrick, 2011). Moreover, lower perceived 44 
consequences and higher personal control have been associated with adherence to insulin 45 
(Broadbent, Donkin, & Stroh, 2011) while higher identity, greater coherence and higher 46 
personal control all predicted foot care (Vedhara et al., 2014). For personal control 47 
specifically, higher levels predicted higher quality of life and exercise behavior (Steed, 48 
Barnard, Hurel, Jenkins, & Newman, 2014). 49 
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Research demonstrates that DD and a variety of illness perceptions link with HbA1c. 50 
The CSM provides an explanation for how cognitive (e.g. illness perceptions), emotional and 51 
behavioral elements interact in the context of chronic illness. The four domains of DD also 52 
involve these same elements; therefore, the CSM would predict that illness perceptions and 53 
DD might interact with one another to influence an outcome such as HbA1c. For example, 54 
items comprising the regimen distress subscale on a measure of DD typically relate to one’s 55 
perception of regimen adherence and their emotions relating to same – e.g. ‘feeling I am 56 
often failing with my diabetes regimen’. This also has some relationship to one’s behavior. 57 
According to the CSM, endorsement of such a statement would overlap with, and influence, 58 
illness perceptions as well as the resulting health outcomes. Additionally, previous evidence 59 
shows moderate correlations between some illness perceptions and diabetes distress (Welch, 60 
Jacobson, & Polonsky, 1997). 61 
Therefore, given the relationships between DD and illness perceptions with HbA1c, 62 
and the theoretical rationale for the interaction between DD and illness perceptions, it is 63 
important to investigate whether the relationship between DD and HbA1c might be mediated 64 
by illness perceptions. Herein, we present our findings from a cross-sectional analysis of DD, 65 
illness perceptions and HbA1c in patients with Type 2 Diabetes that tests the hypothesis that 66 
the link reported between DD and HbA1c is mediated by illness perceptions.  67 
Methods 68 
Participants and procedure 69 
Participants were recruited through diabetes outpatient clinics in a large, urban 70 
hospital between October 2014 and January 2015. Eligibility criteria were pre-defined: age 71 
18 or over and a definite diagnosis of diabetes for greater than one year. Eligible patients who 72 
scheduled and attended appointments in this time period were invited to participate. The 73 
researcher was present to provide assistance in completing the questionnaires if requested by 74 
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participants. Ethical approval for the study was granted by a NHS Research Ethics 75 
Committee. All participants consented to take part in the study. 76 
Measures 77 
All questionnaires were randomly ordered in each pack to prevent order effects. 78 
Diabetes distress. Diabetes distress was measured using the 17-item Diabetes Distress 79 
Scale (DDS17) (Polonsky et al., 2005). DDS17 contains items producing four subscales: 80 
relationship with diabetes physician, emotional burden, regimen-related distress and 81 
interpersonal distress. Items are scored on a Likert scale from 1 (no distress) to 6 (serious 82 
distress) for experiences over the past month. Mean subscale scores of ≥3 indicate clinical 83 
distress. Internal consistency for the four subscales has been reported as .88 to .90 (Polonsky 84 
et al., 2005).  Cronbach’s alpha for this study was similar (emotional burden: .95; physician 85 
distress: .88; regimen distress: .88; interpersonal: .93). Factor analysis has confirmed 86 
independence of the 4 subscales (Polonsky et al., 2005) and DDS17 has been correlated with 87 
HbA1c (Fisher et al., 2010). All four subscale scores are used in our analysis. 88 
Illness perceptions. Illness perceptions were assessed using the Brief Illness 89 
Perception Questionnaire (BIPQ) (Broadbent et al., 2006).  The eight illness perceptions are 90 
measured by one item each and include consequences, timeline, personal control, treatment 91 
control, identity, coherence, emotional representation and illness concern. Participants rate 92 
the strength of each belief on a 10-point Likert scale where 0 = none and 10 = complete. This 93 
scale has shown satisfactory test-retest reliability and moderate to good concurrent validity 94 
with the relative domains in the IPQ-R as well as being validated in a Type 2 DM population  95 
(Broadbent et al., 2006). 96 
Depression. The 9-item Patient Health Questionnaire (PHQ-9) (Kroenke, Spitzer, & 97 
Williams, 2001) was used to measure levels of depression. Participants are asked to answer in 98 
regards to their experiences over the previous two weeks and respond to items using a 4-point 99 
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Likert scale where 0 is not at all and 3 is nearly every day. A cut-off score of 12 was chosen 100 
on the basis of previous analyses of people with diabetes attending outpatient clinics (van 101 
Steenbergen-Weijenburg et al., 2010). Cronbach’s alpha for the current study = .92. 102 
Demographic and clinical variables. Data for participants’ most recent HbA1c 103 
measurement and BMI were obtained from medical records. Participants provided 104 
information on age, gender, marital status, smoking status, duration of diabetes, number of 105 
complications, frequency of blood sugar monitoring in a typical day and whether their 106 
regimen included insulin. Diabetes type, age, gender, duration of diabetes and regimen 107 
information were obtained from or verified with medical records where information provided 108 
by participants was missing or ambiguous. Socioeconomic status (SES) was determined by 109 
using participants’ postcodes to obtain a multiple deprivation measure score for their census 110 
output area.  111 
Statistical analysis 112 
Data for analysis were only included for participants who had complete information 113 
on all included variables. All analysis was conducted using SPSS version 21. Bivariate 114 
correlations were run for all variables with HbA1c. All variables were then entered into a 115 
regression model. A backward regression model was employed to identify the most pertinent 116 
predictors of HbA1c. The Baron and Kenny (1986) approach was used to check whether the 117 
relationship between diabetes distress and HbA1c was mediated by illness perceptions.  118 
Results 119 
Participants 120 
535 people with various types of DM attended clinics during the study period and 121 
were offered questionnaires – 176 of these individuals participated (32.9% response rate). 122 
Thirty-six participants had a diabetes type other than Type 2, 6 participants did not meet the 123 
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inclusion criteria, 2 did not complete consent forms and 48 participants provided incomplete 124 
data. This sample therefore comprises 84 participants with Type 2 DM (Table 1).  125 
-----Insert Table 1 here----- 126 
Means and standard deviations for the DDS17 and BIPQ subscales are in Table 2. 127 
-----Insert Table 2 here----- 128 
Pearson correlations for all variables with HbA1c are presented in Table 3. 129 
-----Insert Table 3 here----- 130 
All variables were entered into a backward regression model to identify the strongest 131 
predictors of HbA1c from those variables measured in the study. Table 4 provides the final 132 
model. This model explains 20% of the variance in HbA1c (F4, 79=6.19, P<.001). 133 
-----Insert Table 4 here----- 134 
The regression model indicates that regimen-related distress and personal control are 135 
the pertinent diabetes distress and illness perceptions variables, respectively.  Therefore, the 136 
Baron and Kenny (1986) approach was used to check whether personal control mediated the 137 
relationship between regimen-related distress and HbA1c. This is a 4 step approach. Step 1 is 138 
to demonstrate a relationship between regimen-related distress and HbA1c. This was r = 139 
0.300, P = .006 (see Table 3). Step 2 is to establish the presence and size of the relationship 140 
between personal control and HbA1c. This was r = -.367, P = .001 (see Table 3). Step 3 is to 141 
determine the relationship between regimen-related distress and personal control. This was r 142 
= -.381, P<.001. Step 4 involves demonstrating that the relationship between regimen-related 143 
distress and HbA1c decreased after personal control was introduced. We used hierarchical 144 
regression to examine this. After personal control was entered into the model, the relationship 145 
between regimen-related distress and HbA1c decreased and became non-significant 146 
(standardised β = .188, P = .091), whereas the relationship between personal control and 147 
HbA1c remained (standardised β = -.296, P = .009). The Sobel test indicated that the 148 
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mediated relationship is significant (Z=2.18, P=.029). The mediating effect is depicted in Fig. 149 
1. 150 
-----Insert Figure 1 here----- 151 
Discussion 152 
To the authors’ knowledge, this is the first study to examine the relationships between 153 
all DD dimensions, illness perceptions and HbA1c. This study has yielded two key findings: 154 
firstly, DD positively correlates with HbA1c in this population and, of the DD domains, 155 
regimen-related distress is most strongly associated with HbA1c, a finding concordant with a 156 
recent analyses in patients with type 1 diabetes (Strandberg et al., 2015) and supported by 157 
interventional studies which have shown that reductions in regimen related distress are 158 
predictive of improved future glycemic control (Hessler et al., 2014). Secondly, the 159 
relationship between regimen-related distress and HbA1c is mediated by personal control; 160 
furthermore, personal control is the strongest covariate of HbA1c when accounting for DD 161 
and other clinical and demographic variables. 162 
Our study provides evidence to suggest that the relationship between regimen-related 163 
distress and HbA1c is an indirect one, mediated by personal control. Previous research linking 164 
DD to HbA1c has primarily utilised the DDS17 total score (e.g. Fisher et al., 2010) rather than 165 
comparing the values of the individual subscales.  Results in this sample concur with 166 
previous studies finding no strong association between depression and HbA1c. Other research 167 
that addressed regimen-related distress alone also found positive relationships between it and 168 
HbA1c (Cummings et al., 2014; Hessler et al., 2014; Pandit et al., 2014). 169 
Personal control is the degree to which individuals feel they can influence the course 170 
of their illness rather than how competent they are at doing so; therefore, it is connected to, 171 
but distinct from, self-efficacy which focuses on competence. Recent research by Gonzalez et 172 
al. (Gonzalez, Shreck, Psaros, & Safren, et al., 2014), published during the course of 173 
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conducting this research, likewise found that personal control mediated the relationship 174 
between one dimension of DD (emotional burden) and HbA1c. In contrast, this study 175 
considered all aspects of DD and found that emotional burden was not as important for HbA1c 176 
as regimen-related distress. Additionally, this study considered all dimensions of the BIPQ 177 
rather than solely personal control. A number of previous studies have implicated personal 178 
control as important for HbA1c and meta-analyses have found a small but significant 179 
association (Hagger & Orbell, 2003; McSharry, Moss-Morris, & Kendrick, 2011).  180 
Not only do the findings here contribute to the literature on the value of personal 181 
control in diabetes, but they also help illuminate the link between DD and HbA1c. The 182 
superior predictive value of personal control over all aspects of DD in this sample is 183 
interesting as previous effect sizes for personal control in relation to HbA1c have been small 184 
(r = -0.12; McSharry et al., 2011). However, effect sizes between DD and HbA1c have been 185 
similarly small (r = .17; Fisher et al., 2010). Our findings support a hypothesis that regimen-186 
related distress is a manifestation of a lack of personal control in Type 2 DM; regimen 187 
distress is important, but its relationship to HbA1c can be explained by the underlying belief 188 
that one cannot affect one’s diabetes. Indeed, Bridges and Smith (2015) have demonstrated 189 
that personal control mediates the relationship between DD and perceptions of the doctor-190 
patient relationship providing further evidence that some of what is conceptualised in DD 191 
may relate to an individual’s sense of control. 192 
There are a number of potentially important clinical implications from this study. 193 
These results suggest that psychological intervention with patients exhibiting moderate or 194 
high diabetes distress may be enhanced in terms of its effects on HbA1c if it addresses 195 
personal control. In fact, some interventions addressing illness perceptions generally have 196 
produced improvements in glycemic control (Keogh et al., 2011). The relative strength of the 197 
relationships between personal control, DD and glycemic control found in this study is 198 
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particularly relevant when considering why previous DD interventions (Berry, Lockhart, 199 
Davies, Lindsay, & Dempster, 2015; Fisher et al., 2013) have not produced significant 200 
improvements in HbA1c.  201 
With the burden of diabetes care falling on  an increasingly time-pressured health-care 202 
system it is essential that these findings are translated into pragmatic, efficacious 203 
interventions. This study suggests that practice might be improved by engaging in a 204 
conversation about patients’ perceptions of their level of control over their diabetes. A simple 205 
way to do this could be to utilise the question measuring this construct in the BIPQ – “on a 206 
scale of 1-10, how much control do you feel you have over your diabetes?” Further to this, 207 
practitioners should look to assess reasons for these beliefs and encourage reflection on their 208 
validity. Any conversation about control should helpfully focus on what patients can control 209 
(e.g. their self-management behaviours) versus what they can only influence indirectly (i.e. 210 
HbA1c readings) in addition to emphasising the normal and expected variation in blood 211 
sugars.  212 
Limitations of this study include its cross-sectional design and limited 213 
generalisability. As a cross-sectional analysis this study is primarily useful for hypothesis 214 
generating. In particular this type of analysis is susceptible to reverse causality. Indeed, our 215 
data could be interpreted as demonstrating that personal control mediates the effect of HbA1c 216 
on diabetes distress – higher HbA1c  may impact upon one’s perceptions of personal control 217 
and this may  increase the distress associated with their diabetes regimen. While this is a 218 
potentially valid interpretation of the data, we find this scenario to be unlikely given that it 219 
has been shown that baseline elevations in diabetes distress predict glycemic control (Aikens, 220 
2012; Strandberg et al., 2015) and that reductions in regimen related distress secondary to a 221 
behavioural intervention are associated with an improvement in future HbA1c (Hessler et al., 222 
2014).   These considerations notwithstanding, our results should be confirmed in larger 223 
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longitudinal analyses where directionality can be more clearly inferred. In addition, 224 
participants included a complex mix of cases with a high proportion on a prescribed insulin 225 
regimen and 80% of participants above the HbA1c target of 53 mmol/mol and was obtained in 226 
a secondary care setting. Therefore, practitioners should extend the recommendations made 227 
above to less complex cases with caution.  228 
In summary, we have demonstrated that personal control mediates the effect of 229 
regimen-related distress on HbA1c.  This exploratory study provides a rationale for a 230 
longitudinal analysis of the inter-relationship between personal control, diabetes distress and 231 
HbA1c across the range of care delivery settings. Furthermore, it justifies the design of 232 
interventional studies addressing personal control in the context of diabetes distress as a 233 
means to improve HbA1c and may provide helpful insight to practitioners hoping to improve 234 
diabetes outcomes with informal psychological interventions. 235 
 236 
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Figure Legend 333 
Figure 1. The mediating effect of personal control on the relationship between diabetes distress 334 
(regimen-related distress) and HbA1c (standardized Beta coefficients displayed). 335 





Table 1. Demographic and clinical characteristics of participants 339 
Study variable Mean (SD) or % 
Age in years 59.3 (12.7) 
Male gender 52.4% 
Living alone 42.9% 
Current smoker 20.2% 
Body Mass Index (kg/m2) 34.5 (6.9) 
Depression 10.0 (7.6) 
Duration in years 9.9 (6.6) 
HbA1c 
<53 mmol/mol (< 7.0%) 
53 to 58 mmol/mol (7.0-7.5%) 
59 to 63 mmol/mol (7.5-7.9%) 
64 to 74 mmol/mol (8.0-8.9%) 







No. of complications 1.3 (1.1) 





Table 2. Means and standards deviations for DDS17 & BIPQ subscales 342 
 343 
 344 
DDS17  Mean (SD) Possible 
Range 
     Emotional burden 2.6 (1.5) 1-6 
     Physician-related distress 1.6 (1.1) 1-6 
     Regimen-related distress 2.5 (1.3) 1-6 
     Interpersonal distress 2.0 (1.4) 1-6 
     DDS17 Total Score 2.2 (1.1) 1-6 
BIPQ    
     Consequences 4.5 (2.6) 0-10 
     Timeline 9.3 (1.7) 0-10 
     Personal control 5.6 (2.3) 0-10 
     Treatment control 7.5 (2.3) 0-10 
     Identity 5.0 (2.5) 0-10 
     Concern 6.0 (3.0) 0-10 
     Coherence 6.8 (2.5) 0-10 
     Emotional representation 5.2 (3.2) 0-10 
21 
 
Table 3. Bivariate correlations for all study variables with HbA1c 345 
Study variable HbA1c P 
Age  -.156 .156 
Gender (1 = male, 2 = female)  .140 .204 
Living status (0 = living alone; 1 = living with partner/spouse) -.078 .480 
SES  .186 .090 
Smoking status (1 = yes, current smoker; 2 = no) -.095 .391 
Body Mass Index  .155 .160 
Duration -.099 .372 
No. of complications -.023 .837 
Insulin (0 = no; 1 = yes)  .081 .463 
Depression   .103 .351 
DDS17    
     Emotional burden  .240 .028 
     Physician-related distress  .150 .175 
     Regimen-related distress  .300 .006 
     Interpersonal distress  .283 .009 
BIPQ    
     Consequences  .104 .345 
     Timeline -.109 .322 
     Personal control -.367 .001 
     Treatment control -.232 .034 
     Identity  .153 .164 
     Concern  .137 .215 
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     Coherence -.192 .080 




Table 4. Standardised beta co-efficients and P-values for the final regression model 347 
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 Standardised  
coefficient (β) 
t P 
SES  .209 2.06 .043 
Taking insulin vs not  .211 2.05 .044 
DDS17    
     Regimen-related distress  .221 2.04 .045 
BIPQ    
     Personal control -.316 2.83 .006 
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Figure 1 356 
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